Ausgabe 3/2016
Inhalt (14 Artikel)
How can we identify candidates at highest risk – to screen or not to screen?
N. C. Barengo, J. O. Tuomilehto
Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic
R. J. King, P. J. Grant
Plötzlicher Herztod bei Diabetes mellitus
C. W. Israel, Y. H. Lee-Barkey
Novel insight into the dangerous connection between diabetes and heart failure
C. Lombardi, V. Spigoni, E. Gorga, A. Dei Cas
Glucose-lowering therapy in type 2 diabetes
G. Schernthaner, G.-H. Schernthaner
Revascularization in complex multivessel coronary artery disease after FREEDOM
K. C. Koskinas, S. Windecker
Admission heart rate in relation to presentation and prognosis in patients with acute myocardial infarction
A. Perne, F.P. Schmidt, M. Hochadel, E. Giannitsis, H. Darius, L.S. Maier, C. Schmitt, G. Heusch, T. Voigtländer, H. Mudra, T. Gori, J. Senges, T. Münzel
Efficacy and safety of zero-fluoroscopy ablation for supraventricular tachycardias
P. Seizer, V. Bucher, C. Frische, D. Heinzmann, M. Gramlich, I. Müller, A. Henning, M. Hofbeck, G. Kerst, M. Gawaz, J. Schreieck
Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromes
Q. Ren, C. Ren, X. Liu, C. Dong, X. Zhang
Thrombo-inflammatory status and prognosis of acute type A aortic dissection
Dong-Ze Li, Jing Yu, Rong-Sheng Du, Rui Zeng, Zhi Zeng
Relationship between neutrophil–lymphocyte ratio and in-hospital mortality
S. Karakoyun, M. Kalçık, M. Yesin
Aktueller Stand der Differenzialtherapie des Vorhofflimmerns
C. Rogge, S. Hilbert, N. Dagres, G. Hindricks